AM-Pharma
Biopharmaceutical company developing recombinant alkanine phosphatase therapies. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD158—236m (Dealroom.co estimates Mar 2020.)
Bunnik Utrecht (HQ)
Authorizing premium user...